Antitumor agents on the production of primary and secondary spleen hemolysin plaque-forming cells.
D000818:Animals; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation / Q000187:drug effects; D000941:Antigens; D000970:Antineoplastic Agents / Q000494:pharmacology*; D003520:Cyclophosphamide / Q000494:pharmacology; D004912:Erythrocytes; D006460:Hemolysin Proteins / Q000096:biosynthesis*; D007166:Immunosuppressive Agents / Q000494:pharmacology; D008297:Male; D008623:Mercaptoethanol / Q000494:pharmacology; D015122:Mercaptopurine / Q000494:pharmacology; D008727:Methotrexate / Q000494:pharmacology; D051379:Mice; D012756:Sheep; D013154:Spleen / Q000187:drug effects*; D014747:Vinblastine / Q000494:pharmacology
D000906:Antibodies; D000941:Antigens; D000970:Antineoplastic Agents; D006460:Hemolysin Proteins; D007166:Immunosuppressive Agents; D014747:Vinblastine; D008623:Mercaptoethanol; D003520:Cyclophosphamide; D015122:Mercaptopurine; D008727:Methotrexate